---
title: "HBC released its performance for the first three quarters, with a net profit attributable to the parent company of 93.11 million yuan, a year-on-year decrease of 57.93%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263139186.md"
description: "According to the Zhitong Finance APP, HBC disclosed its third-quarter report for 2025. The company's revenue for the first three quarters reached 5.927 billion yuan, a year-on-year decrease of 13.02%; the net profit attributable to the parent company was 93.11 million yuan, a year-on-year decrease of 57.93%; the net profit excluding non-recurring gains and losses was 89.69 million yuan, a year-on-year decrease of 58.35%; the basic earnings per share were 0.0117 yuan"
datetime: "2025-10-28T16:09:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263139186.md)
  - [en](https://longbridge.com/en/news/263139186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263139186.md)
---

# HBC released its performance for the first three quarters, with a net profit attributable to the parent company of 93.11 million yuan, a year-on-year decrease of 57.93%

According to the Zhitong Finance APP, HBC (603077.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 5.927 billion yuan in the first three quarters, a year-on-year decrease of 13.02%; the net profit attributable to the parent company was 93.11 million yuan, a year-on-year decrease of 57.93%; the net profit excluding non-recurring gains and losses was 89.69 million yuan, a year-on-year decrease of 58.35%; the basic earnings per share were 0.0117 yuan

### Related Stocks

- [603077.CN](https://longbridge.com/en/quote/603077.CN.md)

## Related News & Research

- [UK biotech could be bound for recovery, BIA report reveals](https://longbridge.com/en/news/284204394.md)
- [Precise Biometrics Shareholders Approve Merger Steps With Fingerprint Cards](https://longbridge.com/en/news/284731647.md)
- [RFK Jr. Blasts "Abhorrent" Assisted Suicide: "We Can't Be A Moral Society If America Follows"](https://longbridge.com/en/news/284119336.md)
- [Coagulation disorder biotech Hemab Therapeutics Holdings sets terms for $200 million IPO, pricing this week](https://longbridge.com/en/news/284219002.md)
- [IDEX Biometrics Publishes 2025 Annual and Remuneration Reports](https://longbridge.com/en/news/284821795.md)